Latest News & Updates
New Speakers and Program Updates Added
More speakers have joined the faculty and the agenda continues to take shape. See the latest program updates and topics covered.
VIEW AGENDAThe Only Event Tailored Directly to Pharma & Biotech Patent Litigators
ACI’s Forum on Pharma and Biotech Patent Litigation USA is now ACI’s Forum on Pharma and Biotech Patent Litigation USA & Canada! This year’s program is bigger and better than ever. Moving beyond the border, we’ll bring together industry leaders in life sciences patent litigation from across the US and Canada for two days of cautionary tales, critical concers, and champion patent litigation strategies. Then, on day 3, we’ll look across the ocean at the flurry of activity in the EU to prepare for the ripple effects on our shores.
Our highly skilled faculty – comprised of premier in-house and law firm patent litigation counsel – will keep you even keeled and ready to tackle the latest challenges facing patent litigators across North America.
Join us in New York for the only bespoke conference tailored directly to the questions, concerns, challenges, and successes of patent litigators in pharma and biotech.
Conference Co-Chairs
Kathryn Jones
VP, Chief Counsel IP
Novo Nordisk
Jacqueline Wright Bonilla, Ph.D.
Director
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Former Deputy Chief Administrative Patent Judge at the Patent Trial and Appeal Board (PTAB)
Nicole Williams
Senior Director of Litigation
10x Genomics
Advisory Board
Meet the industry leaders shaping the future of pharma and biotech patent litigation.
A Must-Attend Event For
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
- Head of Patent Litigation/ IP Litigation
- VP-Intellectual Property
- Head, IP
- IP/Patent Counsel
- Head of Legal / Legal Affairs
- Head of Global IP/Patent Strategy
- Director Innovation, IP, and Portfolio Management
- R&D Patent Manager
- Director of Licensing & Commercialization
Law Firm Attorneys with Practices in:
- Life Sciences/ Pharma-Biotech Intellectual Property/ Patent Litigation
- Life Sciences/ Pharma-Biotech Intellectual Property and Patent Law
Who’s in the Room?
Join senior in-house IP and litigation leaders from leading pharmaceutical, biotech, and life sciences companies already confirmed to attend.
- Moderna
- Novartis
- Sanofi Novo Nordisk
- Merck Sharp & Dohme LLC
- Bristol-Myers Squibb
- Johnson & Johnson
- Eisai
- Ipsen Biopharmaceuticals Inc.
- Servier Pharmaceuticals
- Organon
- Sandoz Inc.
- Xencor
- ORIC Pharmaceuticals Inc.
- Crinetics Pharmaceuticals
- Theravance Biopharma US, Inc.
- 10x Genomics
- Dexcel Pharma
- Bausch Health Companies Inc.
- Merz Pharmaceuticals LLC
- Knoa Pharma LLC
- argenx
Earn CLE Credits
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
Learn moreSponsors & Partners
Supporting Sponsors
Associate Sponsors
Premium Exhibitor
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
